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A 2-transcript host cell signature 
distinguishes viral from bacterial 
diarrhea and it is influenced by the 
severity of symptoms
R. Barral-Arca  1,2,3,4, J. Pardo-Seco1,2,3,4, F. Martinón-Torres3,4 & A. Salas1,2,3,4
Recently, a biomarker signature consisting of 2-transcript host RNAs was proposed for discriminating 
bacterial from viral infections in febrile children. We evaluated the performance of this signature 
in a different disease scenario, namely a cohort of Mexican children (n = 174) suffering from acute 
diarrhea of different infectious etiologies. We first examined the admixed background of the patients, 
indicating that most of them have a predominantly Native American genetic ancestry with a variable 
amount of European background (ranging from 0% to 57%). The results confirm that the RNA test can 
discriminate between viral and bacterial causes of infection (t-test; P-value = 6.94×10−11; AUC = 80%; 
sensitivity: 68% [95% CI: 55%–79%]; specificity: 84% [95% CI: 78%–90%]), but the strength of the 
signal differs substantially depending on the causal pathogen, with the stronger signal being that of 
Shigella (P-value = 3.14 × 10−12; AUC = 89; sensitivity: 70% [95% CI: 57%–83%]; specificity: 100% 
[95% CI: 100%–100%]). The accuracy of this test improves significantly when excluding mild cases (P-
value = 2.13 × 10−6; AUC = 85%; sensitivity: 79% [95% CI: 58%–95%]; specificity: 78% [95% CI: 65%–
88%]). The results broaden the scope of previous studies by incorporating different pathogens, variable 
levels of disease severity, and different ancestral background of patients, and add confirmatory support 
to the clinical utility of these 2-transcript biomarkers.
There are increasing efforts aimed at developing host biomarkers allowing to distinguish viral from bacterial infec-
tions in febrile children1. The interest stems not only from the need to discriminate potentially life-threatening 
bacterial infections from viral infections, but also to avoid the unnecessary prescription of empirical antibiotic 
therapy irrespective of severity. The overuse of antibiotics worldwide is accelerating antimicrobial resistance 
(AMR), which is recognized as one of the greatest threats to human health worldwide2. Furthermore, AMR 
research now constitutes one of the main programs of the World Health Organization (WHO; http://www.who.
int/antimicrobial-resistance/).
There is an increasing interest in discovering diagnostic biomarkers from whole blood gene expression able to 
distinguish viral from bacterial diseases showing similar initial clinical phenotypes3. Two promising approaches 
to this issue based on a RNA signature have been published recently. The study by Mahajan et al.4 detected a 
66-transcript signature in blood that allowed to differentiate bacterial from viral infection in young febrile infants. 
Herberg et al.5 have recently identified a host whole blood RNA transcriptomic signature based on only two 
genes, FAM89A and IFLI44L, and these results were recently validated by Kaforou and colleagues6, again in neo-
nates. The possibility of using only two biomarkers to accurately differentiate viral from bacterial infections makes 
this approach particularly attractive for the design of a test in a simple device for use in health institutions or as a 
point of care test5. However, despite of the encouraging results of these studies, further effort is required to eval-
uate the accuracy and clinical utility of these biomarkers in different clinical settings before they can be turned 
into a clinically applicable test.
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At the same time, the implications of the ancestral background of patients in transcription patterns is very 
poorly approached in the literature. However, some studies demonstrated that gene expression can depend on 
the ancestry background owing to existing differential frequencies at regulatory polymorphisms in populations7. 
Taking the current evidence into account, we propose here a new approach that allows to infer the ancestry from 
transcriptomic data without the need for an ad hoc test. The inferred ancestry can then be used to evaluate the 
possible dependence of expression on genetic background.
The present study differs from previous efforts5 in that: (i) the performance of the 2-transcript host RNA 
signature for discriminating bacterial from viral infection is evaluated in a real-life scenario of children suffering 
from acute diarrhea, (ii) the accuracy of the 2-transcipt test is evaluated for acute diarrhea caused by different 
pathogens, (iii) the discriminatory capacity of this test is measured for different levels of disease severity, and (iv) 
the dataset employed is from Mexico, thus allowing to test the accuracy of these biomarkers in a non-European 
cohort.
Material and Methods
Samples and data. We retrieved from the GEO database8 an RNA expression dataset obtained from a 
cohort (n = 174) of Mexican children, aged less than 10 years old, suffering from acute diarrhea associated with 
a single viral or bacterial pathogen, and without systemic complications (GEO accession number: GSE69529).
Ancestral analysis from RNA data. In order to investigate the ancestral background of the biological 
samples analyzed, RNA data were preliminary processed for the extraction of DNA variant information. We used 
Opossum to pre-process RNA-seq reads prior to variant calling9. Subsequently, Platypus software was used as 
variant caller tool10. A total of 68,327 SNPs could be initially retrieved from the RNA data.
Analysis of ancestral background of patients was carried out using standard procedures (e.g.11,12). Inferring 
ancestral characteristics of the donors requires the use of reference continental populations. Genome data from 
reference populations were retrieved from two SNP genome repositories. From The 1000 Genomes Project13 
(http://www.internationalgenome.org), we used the European-CEU and the African Yoruban-YRI datasets. From 
Reich et al.14 we used different population samples (Aymara, Maya, Pima, Quechua, etc) that represent the Native 
American ancestry, as published previously15; only the Native American variation of these datasets was used for 
the analysis (masked data).
We then intersected the SNPs retrieved from the RNA data and the two reference DNA datasets, resulting in 
a final set of 416 SNPs. It has been shown that a few hundred SNPs can provide accurate population estimates of 
continental ancestry16.
Next, we computed identity-by-state (IBS) values from SNP data using PLINK17. With the aim of exploring 
for clusters of genetic variation in the population sets analyzed, a Multidimensional Scaling (MDS) plot was 
built using a matrix of pairwise individual IBS values. MDS was performed using the function cmdscale (library 
stats) from R (http://www.r-project.org). In addition, we obtained maximum likelihood estimations of individual 
ancestries from multi-locus SNP data using ADMIXTURE software18.
RNA data processing. First of all, we performed a quality control of the raw data obtained from the 
Sequence Read Archive (SRA) using FastaQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc) 
to ensure that there were no problems or biases in our data which might affect the downstream analysis. 
Subsequently, we used MultiQC19 to aggregate the results from FastaQC across many samples into a single 
plot. We eliminated several samples from our analysis [CA234, CA273, CA251, CA287, CA352, CA450, CA68, 
8CA864, CA236] because they had either an incorrect G-C content or many overrepresented sequences20. After 
the quality control of the raw sequencing data, we selected 175 whole blood samples including children infected 
by rotavirus (n = 53), enteroaggregative Escherichia coli (EAEC) (n = 18), enteropathogenic Escherichia coli 
(EPEC) (n = 10), diffuse-adhering Escherichia coli (DAEC) (n = 21), Salmonella (n = 36), and Shigella (n = 36). 
A group of healthy controls was also available in the GEO database, but it was processed only here for the aim of 
ancestry analysis (because the comparisons of virus versus bacterial transcription patterns does not need a group 
of controls5;).
The whole transcriptome reads were mapped against the version of the human genome provided by Ensembl 
(version GRCh38_r90/release 90) using the ultrafast universal RNA-seq aligner STAR21. The aligned reads were 
reported in BAM format. We also used STAR for counting the number of reads that map to each gene.
Using the Integrative Genomics Viewer (IGV)22 we visualized where the mapped reads were positioned in 
the genes of interest. Last, we normalized the reads using several methods, including RPKM (Reads per million 
mapped reads), TMM (Trimmed mean of M-values), CQN (Conditional quantile normalization), and Deseq2 
implemented in the Deseq2 package of the R statistical software (https://www.r-project.org). All the methods 
yielded virtually the same result; Deseq2 was finally chosen.
Boxplots were built using the R package beeswarm (https://cran.r-project.org/web/packages/beeswarm) 
to represent the Disease Risk Score (DRS)5 according to the type of infection and pathogen. Given that the 
2-transcript signature in our dataset follows a normal distribution (Shapiro test; P-value > 0.05), we used the 
T-test for independent samples to evaluate the statistical significance of the differential expression in bacterial 
vs. viral infected patients. In addition, to evaluate the predictive accuracy of the 2-transcript signature we con-
structed Receiver Operating Characteristic (ROC) curves and the area under the curves (AUC) using the pROC 
package in R. The threshold value, defined as the point on the ROC curve that maximized sensitivity and spec-
ificity, was calculated using the R package OptimalCutPoints23. The calculation of the confidence intervals for 
sensitivity and the specificity was based on a stratified bootstrap resampling.
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Results
Ancestry analysis. Admixture analysis of the RNA data in virus, bacteria, and control cohorts indicates that 
the predominant ancestry is clearly Native American (average values: virus = 76.8% [range = 44.7-96.8], bacte-
ria = 76.9% [range = 33.4-100], controls = 77.7 [range = 46–93.7]); the three datasets contain substantial levels of 
European ancestry too (average values: virus = 19.4%, bacteria = 19.4%; controls = 17.4%) (Fig. 1A). On average, 
Native American and European ancestries in patients are 77.0% and 19.2%, respectively.
The MDS plot of virus, bacteria, and control groups, together with the three main continental reference pop-
ulations is in good concordance with the admixture analysis (Fig. 1B). There are three main poles of ancestry in 
the MDS plots, coinciding with the main three continental groups: Native Americans, Europeans, and Africans. 
Patients and controls fall closely related to the Native American cluster; a few samples are slightly projected the 
European cluster, indicating a more marked European ancestry in their genomes.
The 2-transcript RNA signature in virus versus bacteria. We first examined if patients clustered according 
to their disease status (bacterial vs. viral infection) when applying the DRS. We generated a one-dimensional 
scatter plot with closely-packed but non-overlapping points (Fig. 2A), which shows a statistically significant dif-
ference in the DRS of children affected by bacterial diarrhea compared to those suffering from viral diarrhea 
(P-value = 6.94 × 10−11). The results are consistent with those obtained by Herberg et al.5 in that a higher DRS 
indicates bacterial infection, whereas a lower DRS indicates viral infection.
Figure 1. Ancestry analysis of RNA samples based on SNP data. (A) Barplot of maximum likelihood 
estimations of individual ancestries, indicating that most patients have a main Native American ancestry, while 
European ancestry is present in a few of them with values ranging from 0% to 57.7%. (B) MDS plot of pairwise 
individual IBS values showing that the genome profile of patients and controls (labeled in the figure as control, 
bacteria and rotavirus) falls close to the Native America cluster (identified by several population samples 
of Native American ethnic origin), and some of the samples slightly displaced towards the European pole 
represented by CEU in Dimensions 1 and 2.
Figure 2. Classification performance based on the 2-transcript DRS combined as [log2(FAM89expresion)–
log2(ILF44Lexpression)]. (A) Box and whisker plot of DRS: the horizontal lines in the boxes indicate the 
median of each group; the lower and upper edges of boxes reflect interquartile ranges, and the whiskers are 
<1 times the interquartile range; the horizontal grey line is the DRS threshold that maximizes the AUC 
when comparing patients with viral and bacterial infections. (B) ROC curves of different bacteria compared 
to rotavirus; the different colors identify the type of bacteria according to the inset legend. AUC values are 
provided in Table 1.
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The diagnostic accuracy of the test to discriminate viral from bacterial diarrhea was evaluated using ROC 
analysis (Fig. 2B), and considering different scenarios: (i) all the bacterial infections against rotavirus, and (ii) 
each bacterial pathogen (EAEC, DAEC, EPEC, Salmonella, and Shigella) against rotavirus. For the first scenario, 
the ROC curve indicates that the accuracy of the test is ~80%, a value that is comparable to that reported by 
Herberg et al. (namely, AUC = ~90%). At the same time, the diagnostic performance of the 2-transcript test seems 
to be pathogen-dependent (Fig. 2B), with some bacterial infections showing more distinctive pattern than viral 
infections; for example, the AUC for Shigella is very high (AUC = 89.0%; 95% CI: 82.5–95.6), while this is more 
moderate for EAEC (AUC = 68.7%; 95% CI: 54.0-83.3). In most of the comparisons carried out considering the 
different groups of bacteria independently, the differential expression in bacterial vs. viral infections was highly 
statistically significant, surpassing the Bonferroni threshold; in cases not showing statistical significance, this 
could be due to small sample sizes, since most are close to the limit of the significance threshold; Table 1).
Most interesting is the observation that the level of severity affects the accuracy of the 2-biomarker test. 
Thus, patients with mild disease introduce noise in the capacity of the two biomarkers to characterize bacte-
rial from viral infections; when these patients are excluded, the signal improves substantially as reflected in the 
boxplots in Fig. 3B,C; the difference with respect to viral infection is still statistically significant in both groups 
of patients, severe + moderate (P-value = 2.13 × 10−06) and mild (P-value = 8.15 × 10−06) cases (Table 1). This 
difference is also evident when examining the ROCs obtained by considering different levels of severity (Fig. 3A; 
AUCMILD = 77.0% vs. AUCSEVERE+MODERATE = 85.3%; AUCSEVERE = 85.0%; AUCMODERATE = 89.2%).
Finally, a correlation analysis between the 2-transcript test and the different ancestral coefficients indicate that 
expression of these two genes is not correlated with ancestral background (Fig. S1 from Supplementary Data).
Discussion
It is common practice in hospitals to administer antibiotics to febrile children until the culture results are avail-
able5. Antibiotics are generally prescribed out of fear of missing a bacterial infection, and such practice is con-
tributing to the rise of drug-resistant pathogens all over the world1. To give some examples, according to the 
data presented by Craig et al.24 on a prospective cohort study of >15,700 febrile illnesses, antibiotics were pre-
scribed acutely in 66% to 81% of children (depending on the type of infection); while 20% of patients without 
bacterial infection received also antibiotic treatment. According to another study on meningitis, no pathogen 
was identified in 50%–80% of the patients but most of them received antibiotics, and almost 50% were (prob-
ably unnecessarily) hospitalized for more than a week25. Nijman et al.26 stated that “a prediction model should 
discriminate between children at high and low risk of serious bacterial infections […] This is helpful to identify 
n AUC Sensitivity Specificity DRS P-value
All patients
Rotavirus 53 — — — —
EAEC 18 68.7 (54.0-83.3) 69.8 (56.6–81.1) 66.7 (44.4–88.9) −6.76 2.160 × 10–2
EPEC 10 78.6 (66.1–90.9) 60.4 (47.2–73.6) 90.0 (70.0–100.0) −7.74 8.879 × 10−3
DAEC 21 73.6 (61.7–85.5) 67.9 (54.7–81.1) 76.2 (57.1–90.5) −7.21 2.494 × 10−3*
Salmonella 36 80.8 (71.9–89.6) 67.9 (54.7–79.2) 83.3 (69.4–94.4) −7.41 6.927 × 10−7*
Shigella 36 89.0 (82.5–95.6) 69.8 (56.6–83.0) 100.0 (100.0–100.0) −6.88 3.140 × 10−12*
All Bacteria 121 80.0 (72.6–87.4) 67.9 (54.7–79.2) 84.3 (77.7–90.1) −7.41 6.944 × 10−11*
Severe & Moderate
Rotavirus 19 — — — —
EAEC 6 58.8 (28.4–89.2) 79.0 (57.9–94.7) 33.3 (0.0–66.7) −6.25 6.102 × 10−1
EPEC 3 84.2 (52.3–100.0) 100.0 (100.0–100.0) 66.7 (0.0–100.0) −4.37 1.780 × 10−1
DAEC 6 86.0 (66.6–100.0) 89.5 (73.7–100.0) 66.7 (33.3–100.0) −5.80 4.057 × 10−2
Salmonella 12 83.3 (69.0–97.6) 68.4 (47.4–89.5) 83.3 (58.3–100.0) −7.41 5.879 × 10−3*
Shigella 22 93.5 (86.6–100.0) 73.7 (52.6–94.7) 100.0 (100.0–100.0) −6.75 2.219 × 10−7*
All bacteria 49 85.3 (75.7–94.9) 79.0 (57.9–94.7) 77.6 (65.3–87.8) −6.40 2.126 × 10−6*
Mild
Rotavirus 34 — — — — —
EAEC 12 73.5 (57.6–89.5) 67.7 (47.1–82.4) 75.0 (0.5–100.0) −6.76 1.818 × 10−2
EPEC 7 74.8 (59.3–90.3) 67.7 (47.1–82.4) 100.0 (100.0–100.0) −7.57 4.668 × 10−2
DAEC 15 69.0 (53.9–84.2) 64.7 (47.1–79.4) 80.0 (60.0–100.0) −7.78 3.601 × 10−2
Salmonella 24 80.0 (68.6–91.4) 67.7 (53.0–82.4) 66.7 (83.3–95.8) −7.55 4.698 × 10−5*
Shigella 14 84.2 (73.4–95.1) 67.7 (52.9–82.4) 100.0 (100.0–100.0) −6.88 1.157 × 10−5*
All bacteria 72 77.0 (66.5–87.4) 67.7 (50.0–82.4) 86.1 (77.8–93.1) −7.57 8.154 × 10−6*
Table 1. AUC values and DRS for different pathogens. Figures in round brackets show the CI 95% (2,000 
bootstrap replicates). P-values evaluate the significance of the difference between bacterial pathogen vs. 
viral infection under a t-test; an asterisk. (*) indicates those values surpassing a Bonferroni correction for 
multiple tests. Note that the reference viral pathogen in our study is rotavirus (for which there is only very little 
information available in the literature; e.g.43).
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children who may need further tests, such as additional blood tests or chest radiography, and guide the need for anti-
biotic prescribing”. On the other hand, culture of bacteria from normally sterile sites may be negative in scenarios 
where the infection resides in inaccessible sites, when the patient received antibiotic previously, or when the 
culture media selected fail to grow certain bacteria5,27. According to the meta-analysis carried out by Iroth Tam 
et al.28, blood culture identifies organisms in only a very small percentage of patients (~5%) suffering pediatric 
community-acquired pneumonia (CAP) (predominantly S. pneumoniae); this result was also corroborated by 
Kwon et al.29, who claimed the low utility of blood culture in CAP in an observational study considering >2,700 
patients. In addition, while some authors defend the utility of MALDI-TOF as a new rapid technology for micro-
bial identification30, the results from conventional cultures of bacteria may take several days5,27,30, so physicians 
commonly make the decision to administer preventive antibiotic treatment25,31.
In this scenario, developing a cost-effective device to differentiate viral from bacterial infections in early stages 
is one of the biggest challenges in medical research. In 2016, Herberg et al.5, published a study that shed new light 
on this problem as they identified a simple blood 2-transcript RNA expression signature that distinguishes viral 
from bacterial infection in febrile children.
Our study adds further support to these findings and also broadens the scope of the initial research. First, the 
Herberg et al.5 study focused on a number of well-selected viral and bacterial febrile patients that needed inten-
sive care or had severe infections (e.g. sepsis); whereas the data set investigated here consisted of children affected 
by diarrhea caused by several pathogens, and thus a cohort that might represent a frequent scenario in emergency 
departments or outpatient clinics. Our results indicate that the 2-transcript test performs differently in different 
infectious scenarios, with the best results shown for diarrhea caused by Shigella.
Second, the majority of the pathogens included in the Mexican database (e.g. Shigella, Rotavirus) had not been 
tested in the original study or, as in the case of E. coli and Salmonella, our study adds more cases and different 
strains. This supports the conclusion that the test seems to perform differently depending on the pathogen.
Third, the database explored here included children with mild, moderate and severe symptomatology, which 
allowed us to assess the 2-transcript signature ranked by levels of severity. The results show that the test performs 
better in patients suffering from moderate to severe symptoms of diarrhea.
Fourth, we measured the potential dependence of the 2-transcript test on the ancestral background of patients. 
To the best of our knowledge, this is the first time that genetic background is inferred from transcriptomic data 
aiming at evaluating its potential effect on gene expression. Commonly, self-reported ancestry is used to strat-
ify the statistical analyses; e.g.32; and in a number of studies, although well-differentiated ancestral groups were 
analyzed, there is no indication on how the ancestral background was assessed33. The exception to this com-
mon practice is Serrano-Gómez et al.34; this study used ancestry-informative markers (AIMs)16 to measure the 
ancestry as a potential modifier of gene expression in breast cancer. The original dataset used by Herberg et al.5 
included patients of main European ancestry (UK, Spain, the Netherlands, and USA); while our sample repre-
sents a Mesoamerican population with predominantly Native American ancestry but variable levels of admixture. 
However, our results indicate that the 2-trancript test performs well in a different background to the one used 
for its discovery35, and that there is no correlation between the expression signal and the ancestral background 
of patients.
Last but not least, the original study used data provided by different microarray platforms; the batch effects 
were targeted computationally. The entire Mexican dataset was generated using RNA-seq and the sequencer 
Illumina HiSeq2500, and therefore batch effects should be minimal.
There are several further considerations from the present study. The results indicate that the 2-biomarkers 
test performs much better in severe patients (more closely related to those examined by Herberg et al.5). We have 
exclusively analyzed cases with a single infecting pathogen, but it would most interesting to further explore the 
behavior of this 2-biomarker test in scenarios of coinfection36–38. The translation of this 2-biomarker test into 
a clinical setup still needs further validation; and this validation would require the analysis of more virus and 
Figure 3. Classification performance based on the 2-transcript DRS combined as [log2(FAM89expresion)–
log2(ILF44Lexpression)] and considering different levels of severity. (A) ROC curves of different bacteria 
compared to rotavirus; AUC values by pathogen are provided in Table 1; and (B) and (C) box and whisker plots 
of DRS for moderate plus severe cases and mild cases, respectively.
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bacteria scenarios, as well as different time points in the course of the same infection, or the case of parasitic 
infections. Despite its limitations, the present study (together with the previous ones5,6) represents a step forward 
towards a bench to bedside test that could help make decisions for antibiotic administration3. It is now possible to 
test transcription signatures using portable devices39–41, so these techniques will be most helpful in small hospitals 
in rural and isolated areas, and in hospitals from developing countries. In addition, although the signal provided 
by IFI44L and FAM89A transcripts is not as strong in diarrhea patients as in more severe disease scenarios5, the 
evidence points to an important role of these two genes in the differential molecular mechanisms employed by 
virus and bacteria for infection. These observations should attract further research exploring the role of these 
genes and related pathways under the hypothesis that both could be key at understanding mechanisms of infec-
tions. To the best of our knowledge, there is very little information available for these two genes, but the FAM89A 
(interferon-induced protein 44-like) is known to exhibit antiviral activity42.
Summarizing, in all of the scenarios tested, our results suggest that these two biomarkers, IFI44L and FAM89A 
transcripts, provide a strong signal to differentiate bacterial from viral infections, a signal that is non-population 
dependent, and useful for discriminating a wide range of pathogens and different levels of severity. Further stud-
ies focusing on the time point of the disease, testing new (portable) devices for RNA typing, and targeting differ-
ent populations worldwide and a wider spectrum of pathogens will be necessary to further confirm the accuracy 
of this biomarker test before it can be turned into a clinically applicable test.
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